Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography | 20 | 2023 | 4989 | 1.260 |
Why?
|
Heart Ventricles | 16 | 2019 | 3807 | 0.930 |
Why?
|
Marfan Syndrome | 7 | 2020 | 236 | 0.840 |
Why?
|
Atenolol | 7 | 2020 | 99 | 0.760 |
Why?
|
Heart Defects, Congenital | 19 | 2021 | 4671 | 0.760 |
Why?
|
Losartan | 7 | 2020 | 265 | 0.680 |
Why?
|
Norwood Procedures | 6 | 2019 | 192 | 0.560 |
Why?
|
Echocardiography, Doppler | 7 | 2019 | 897 | 0.440 |
Why?
|
Hypoplastic Left Heart Syndrome | 6 | 2018 | 594 | 0.420 |
Why?
|
Enalapril | 4 | 2019 | 312 | 0.410 |
Why?
|
Ventricular Function, Right | 4 | 2019 | 617 | 0.410 |
Why?
|
Heart | 4 | 2023 | 4404 | 0.400 |
Why?
|
Ventricular Septum | 1 | 2011 | 76 | 0.360 |
Why?
|
Pulmonary Atresia | 1 | 2011 | 159 | 0.350 |
Why?
|
Cardiology | 2 | 2023 | 1656 | 0.330 |
Why?
|
Ultrasonography, Prenatal | 7 | 2021 | 1755 | 0.320 |
Why?
|
Fetal Heart | 2 | 2010 | 281 | 0.320 |
Why?
|
alpha-Glucosidases | 1 | 2008 | 45 | 0.310 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2008 | 43 | 0.310 |
Why?
|
Pregnancy in Diabetics | 1 | 2010 | 197 | 0.310 |
Why?
|
Coronary Vessel Anomalies | 1 | 2011 | 307 | 0.300 |
Why?
|
Blalock-Taussig Procedure | 3 | 2019 | 60 | 0.300 |
Why?
|
Aortic Diseases | 3 | 2018 | 735 | 0.270 |
Why?
|
Aorta | 5 | 2018 | 2042 | 0.260 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1423 | 0.250 |
Why?
|
Heart Bypass, Right | 2 | 2017 | 75 | 0.240 |
Why?
|
Point-of-Care Systems | 2 | 2023 | 1213 | 0.230 |
Why?
|
Education, Medical | 1 | 2015 | 1725 | 0.220 |
Why?
|
Infant | 25 | 2023 | 36192 | 0.210 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 5 | 2020 | 431 | 0.210 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2021 | 607 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2017 | 1516 | 0.190 |
Why?
|
Pediatrics | 2 | 2017 | 3589 | 0.180 |
Why?
|
Pulmonary Artery | 3 | 2013 | 1927 | 0.180 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 52 | 0.180 |
Why?
|
Fetus | 3 | 2021 | 1863 | 0.170 |
Why?
|
Clinical Competence | 1 | 2015 | 4792 | 0.170 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1310 | 0.160 |
Why?
|
Ventricular Remodeling | 3 | 2019 | 1267 | 0.160 |
Why?
|
Ventricular Pressure | 1 | 2019 | 210 | 0.160 |
Why?
|
Aortic Coarctation | 1 | 2001 | 275 | 0.160 |
Why?
|
Mitral Valve Stenosis | 1 | 2001 | 341 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 4 | 2021 | 3627 | 0.150 |
Why?
|
Infant, Newborn | 16 | 2021 | 26198 | 0.140 |
Why?
|
Aortic Valve Stenosis | 3 | 2007 | 2001 | 0.130 |
Why?
|
Antihypertensive Agents | 4 | 2019 | 2024 | 0.130 |
Why?
|
Arteries | 1 | 2001 | 1123 | 0.130 |
Why?
|
Heart Aneurysm | 1 | 1995 | 114 | 0.120 |
Why?
|
Cerebrovascular Circulation | 2 | 2016 | 2727 | 0.120 |
Why?
|
Data Collection | 1 | 2023 | 3322 | 0.110 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1265 | 0.110 |
Why?
|
Situs Inversus | 1 | 1993 | 63 | 0.110 |
Why?
|
Pregnancy Trimester, Second | 2 | 2021 | 731 | 0.110 |
Why?
|
Atrioventricular Node | 1 | 1993 | 180 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2001 | 1161 | 0.100 |
Why?
|
Aneurysm, False | 1 | 1995 | 255 | 0.100 |
Why?
|
Tricuspid Valve | 2 | 2014 | 410 | 0.100 |
Why?
|
Calcinosis | 1 | 2001 | 1469 | 0.100 |
Why?
|
Child | 16 | 2023 | 80153 | 0.100 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 3 | 2020 | 30 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5840 | 0.090 |
Why?
|
Catheterization | 2 | 2007 | 1428 | 0.090 |
Why?
|
Child, Preschool | 15 | 2020 | 42230 | 0.090 |
Why?
|
Tachycardia | 1 | 1993 | 600 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20098 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2011 | 190 | 0.090 |
Why?
|
Fetal Development | 1 | 2016 | 769 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1468 | 0.090 |
Why?
|
Aortic Aneurysm | 1 | 2014 | 648 | 0.080 |
Why?
|
Treatment Outcome | 14 | 2021 | 64680 | 0.080 |
Why?
|
Humans | 46 | 2023 | 761504 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1489 | 0.080 |
Why?
|
Ventricular Function | 1 | 2011 | 406 | 0.080 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2014 | 628 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1241 | 0.080 |
Why?
|
Palliative Care | 3 | 2019 | 3598 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2014 | 796 | 0.080 |
Why?
|
Female | 30 | 2021 | 392644 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3879 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 737 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2013 | 696 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2021 | 15631 | 0.060 |
Why?
|
Image Enhancement | 1 | 2016 | 2885 | 0.060 |
Why?
|
Stroke Volume | 3 | 2015 | 5496 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39106 | 0.060 |
Why?
|
Male | 25 | 2021 | 360804 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1723 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2011 | 1569 | 0.060 |
Why?
|
Fetal Therapies | 1 | 2006 | 101 | 0.060 |
Why?
|
Myocardium | 2 | 2021 | 4726 | 0.060 |
Why?
|
Maternal Health Services | 1 | 2010 | 461 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2020 | 80636 | 0.060 |
Why?
|
Diastole | 2 | 2019 | 782 | 0.060 |
Why?
|
Pregnancy | 7 | 2021 | 29874 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2219 | 0.050 |
Why?
|
Pulsatile Flow | 2 | 2016 | 321 | 0.050 |
Why?
|
Adolescent | 12 | 2020 | 88319 | 0.050 |
Why?
|
Middle Cerebral Artery | 2 | 2016 | 275 | 0.050 |
Why?
|
Boston | 2 | 2016 | 9326 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2850 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2019 | 12341 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1400 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 1302 | 0.050 |
Why?
|
Young Adult | 7 | 2021 | 59243 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54425 | 0.050 |
Why?
|
North America | 2 | 2017 | 1276 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3801 | 0.050 |
Why?
|
Systole | 2 | 2014 | 936 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2306 | 0.050 |
Why?
|
Linear Models | 3 | 2018 | 5871 | 0.050 |
Why?
|
Adult | 14 | 2023 | 221177 | 0.050 |
Why?
|
Baltimore | 1 | 2001 | 231 | 0.040 |
Why?
|
Catheter Ablation | 1 | 1993 | 2751 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2005 | 870 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2001 | 352 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4471 | 0.040 |
Why?
|
Electrocardiography | 2 | 2008 | 6377 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2001 | 1834 | 0.040 |
Why?
|
Gestational Age | 3 | 2016 | 3577 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9646 | 0.040 |
Why?
|
Patient Selection | 2 | 2012 | 4244 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6534 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 787 | 0.040 |
Why?
|
Organ Size | 2 | 2014 | 2254 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1039 | 0.040 |
Why?
|
Thorax | 1 | 2021 | 555 | 0.040 |
Why?
|
Biometry | 1 | 2021 | 563 | 0.040 |
Why?
|
Sodium Channels | 1 | 1999 | 339 | 0.040 |
Why?
|
Risk Factors | 5 | 2021 | 74206 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2005 | 1265 | 0.040 |
Why?
|
Quality of Life | 1 | 2018 | 13367 | 0.030 |
Why?
|
Missouri | 1 | 2016 | 114 | 0.030 |
Why?
|
Dilatation | 1 | 2018 | 306 | 0.030 |
Why?
|
Vena Cava, Superior | 1 | 1997 | 195 | 0.030 |
Why?
|
Aldosterone | 2 | 2011 | 870 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 267 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2001 | 913 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12725 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1999 | 1494 | 0.030 |
Why?
|
Medical Records | 1 | 2001 | 1408 | 0.030 |
Why?
|
Electronic Mail | 1 | 2017 | 213 | 0.030 |
Why?
|
Long QT Syndrome | 1 | 1999 | 467 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2005 | 3096 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14666 | 0.030 |
Why?
|
Bundle of His | 1 | 1993 | 101 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.030 |
Why?
|
United States | 4 | 2023 | 72334 | 0.030 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1993 | 116 | 0.030 |
Why?
|
Ebstein Anomaly | 1 | 1993 | 105 | 0.030 |
Why?
|
Reoperation | 2 | 2012 | 4303 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 2001 | 1304 | 0.020 |
Why?
|
Genotype | 2 | 2020 | 12990 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39967 | 0.020 |
Why?
|
Heart Failure | 2 | 2017 | 11669 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12463 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 23995 | 0.020 |
Why?
|
Angiotensins | 1 | 2011 | 143 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3579 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2606 | 0.020 |
Why?
|
Mutation, Missense | 1 | 1999 | 2571 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2014 | 576 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15842 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2013 | 930 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1995 | 952 | 0.020 |
Why?
|
Ultrasonography | 1 | 2022 | 5972 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 362 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12059 | 0.020 |
Why?
|
Renin | 1 | 2011 | 641 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2011 | 678 | 0.020 |
Why?
|
Vasodilation | 1 | 2013 | 962 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 983 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2979 | 0.020 |
Why?
|
Survival Analysis | 1 | 2001 | 10090 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13255 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1271 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2014 | 14605 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29625 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6484 | 0.020 |
Why?
|
Syndrome | 1 | 1993 | 3267 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3416 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7212 | 0.020 |
Why?
|
Abortion, Therapeutic | 1 | 2006 | 35 | 0.020 |
Why?
|
Hemodynamics | 2 | 2007 | 4159 | 0.020 |
Why?
|
Growth Disorders | 1 | 2011 | 655 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1792 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5428 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6228 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6814 | 0.010 |
Why?
|
Fetal Death | 1 | 2006 | 435 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2005 | 527 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21353 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8631 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4124 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2176 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4227 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2628 | 0.010 |
Why?
|
Recurrence | 1 | 1993 | 8465 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.010 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 536 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2012 | 3233 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6425 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5294 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4431 | 0.010 |
Why?
|
Fever | 1 | 2005 | 1618 | 0.010 |
Why?
|
Middle Aged | 2 | 2010 | 220895 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2007 | 2921 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1229 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18395 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1738 | 0.010 |
Why?
|
Infant, Premature | 1 | 2005 | 2107 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3929 | 0.010 |
Why?
|
Pedigree | 1 | 1999 | 4542 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4615 | 0.010 |
Why?
|
Heart Atria | 1 | 1997 | 1345 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12974 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5439 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41487 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1997 | 2244 | 0.000 |
Why?
|
Brain | 1 | 2013 | 27112 | 0.000 |
Why?
|
Genetic Variation | 1 | 1999 | 6567 | 0.000 |
Why?
|
Aged | 1 | 1997 | 169289 | 0.000 |
Why?
|